Preclinical Evaluation of Sunitinib as a Single Agent in the Prophylactic Setting in a Mouse Model of Bone Metastases

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-13-32
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer

Science Translational Medicine
Medicine
2012English

Humanized Bone Marrow Mouse Model as a Preclinical Tool to Assess Therapy-Mediated Hematotoxicity

Clinical Cancer Research
Cancer ResearchOncology
2011English

Preclinical Evaluation of SOM230 as a Radiation Mitigator in a Mouse Model: Postexposure Time Window and Mechanisms of Action

Radiation Research
Nuclear MedicineRadiologyRadiationImagingBiophysics
2011English

Taurolidine: Preclinical Evaluation of a Novel, Highly Selective, Agent for Bone Marrow Purging

Bone Marrow Transplantation
TransplantationHematology
2002English

Wenshen Zhuanggu Formula Effectively Suppresses Breast Cancer Bone Metastases in a Mouse Xenograft Model

Acta Pharmacologica Sinica
MedicinePharmacology
2017English

Preclinical Evaluation of Liposomal C8 Ceramide as a Potent Anti-Hepatocellular Carcinoma Agent

PLoS ONE
Multidisciplinary
2016English

Early Evaluation Predicts Pain Relief of Irradiated Bone Metastases: A Single-Center Prospective Study

BMC Palliative Care
Medicine
2013English

Evaluation of Bone Metastases in Lung Cancer

Cancer Control
MedicineOncologyHematology
2002English

Prophylactic and Therapeutic Activities of Azithromycin in a Mouse Model of Pneumococcal Pneumonia.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy